Novel Applications of Anti-CD25 Antibody-Maytansine Conjugates
Legal Citation
Summary of the Inventive Concept
This inventive concept explores the application of anti-CD25 antibody-maytansine conjugates in various non-medical fields, including agriculture, environmental monitoring, and personal care, offering novel solutions for crop health monitoring, soil contaminant detection, waterborne pathogen detection, skin condition treatment, and air quality monitoring.
Background and Problem Solved
The original patent disclosed anti-CD25 antibody-maytansine conjugates for therapeutic applications. However, these conjugates have untapped potential in other industries. The inventive concept addresses the limitations of the original patent by exploring new use cases, providing innovative solutions for various industries.
Detailed Description of the Inventive Concept
The new claims describe the application of anti-CD25 antibody-maytansine conjugates in non-medical fields. For instance, claim 1 proposes a system for monitoring crop health by applying the conjugate to plants, which binds to CD25 receptors on plant cells, indicating the health of the plant. Claim 2 describes a method for detecting soil contaminants by adding the conjugate to soil samples, where it binds to CD25 receptors on microorganisms, indicating the presence of contaminants. Similarly, claims 3-5 propose devices and compositions for detecting waterborne pathogens, treating skin conditions, and monitoring air quality, respectively.
Novelty and Inventive Step
The new claims introduce novel applications of anti-CD25 antibody-maytansine conjugates, which are non-obvious and distinct from the original therapeutic applications. The inventive step lies in the unexpected use of these conjugates in non-medical fields, providing innovative solutions for various industries.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include modifying the conjugate structure, using different types of antibodies or maytansinoids, or combining the conjugate with other molecules to enhance its functionality. Variations could include applying the conjugate to different types of plants, soil, or water samples, or using it for detecting other types of contaminants or pathogens.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including agriculture, environmental monitoring, personal care, and healthcare. The market for these applications is substantial, with potential customers including farmers, environmental monitoring agencies, skincare companies, and healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/6807 |
| C | C07 | C07K16/2866 |
| A | A61 | A61K47/65 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and protein engineering, specifically antibody-drug conjugates with a focus on targeted therapeutic and diagnostic molecular platforms
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in molecular biology, biochemistry, or bioengineering, possessing expertise in antibody design, conjugation techniques, receptor targeting, and interdisciplinary applications of molecular targeting technologies
Obviousness Rationale
A PHOSITA would recognize that the core anti-CD25 antibody-maytansine conjugate technology represents a versatile molecular platform with potential applications beyond the original therapeutic context. The fundamental molecular mechanism of receptor binding and targeted interaction remains consistent across different application domains, suggesting that adapting the conjugate to alternative uses would be a predictable extension of the source patent's core technological innovation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,637 |
|---|---|
| Title | Anti-CD25 antibody-maytansine conjugates and methods of use thereof |
| Assignee(s) | R.P. Scherer Technologies, LLC |